- Report
- December 2025
- 150 Pages
Global
From €4361EUR$4,850USD£3,738GBP
- Report
- October 2025
- 150 Pages
Global
From €4361EUR$4,850USD£3,738GBP
- Report
- March 2026
- 198 Pages
Global
From €4491EUR$4,995USD£3,850GBP
- Report
- January 2026
- 200 Pages
Global
From €4491EUR$4,995USD£3,850GBP
- Report
- July 2026
- 160 Pages
Global
From €3731EUR$4,150USD£3,199GBP
- Report
- February 2026
- 89 Pages
Global
From €3500EUR$4,170USD£3,105GBP
- Report
- September 2025
- 142 Pages
Global
From €3500EUR$4,170USD£3,105GBP
- Report
- September 2025
- 130 Pages
Global
From €4361EUR$4,850USD£3,738GBP
- Report
- September 2025
- 150 Pages
Global
From €4361EUR$4,850USD£3,738GBP
- Report
- February 2026
- 170 Pages
Global
From €4361EUR$4,850USD£3,738GBP
- Report
- March 2026
- 135 Pages
Global
From €4361EUR$4,850USD£3,738GBP
- Report
- January 2026
- 190 Pages
Global
From €4451EUR$4,950USD£3,815GBP
- Report
- January 2026
- 97 Pages
Global
From €3102EUR$3,450USD£2,659GBP
- Report
- November 2025
- 52 Pages
Global
From €6743EUR$7,500USD£5,781GBP
- Report
- November 2025
Global
From €6743EUR$7,500USD£5,781GBP
- Report
- October 2025
- 85 Pages
Global
From €4046EUR$4,500USD£3,468GBP
- Report
- February 2026
- 150 Pages
United States
From €2696EUR$2,999USD£2,312GBP
€3596EUR$3,999USD£3,082GBP
- Report
- November 2025
- 111 Pages
Europe
From €2922EUR$3,250USD£2,505GBP
- Report
- November 2025
- 101 Pages
Asia Pacific
From €2922EUR$3,250USD£2,505GBP
- Report
- November 2025
- 60 Pages
United States
From €2293EUR$2,550USD£1,965GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more